
|Articles|June 24, 2004
ASCO submits proposals on CPT code changes for infused drugs
The American Society of Clinical Oncology has submitted a series of proposals to an AMA workgroup aimed at changing a number of CPT codes for infused drugs.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











